Patent details

EP1194167 Title: IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS USING ANTIBODIES WHICH TARGET B-CELLS

Basic Information

Publication number:
EP1194167
PCT Application Number:
PCT/US/2000/015780
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009412784
PCT Publication Number:
WO/2000/074718
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS USING ANTIBODIES WHICH TARGET B-CELLS
French Title of Invention:
IMMUNOTHERAPIE DE TROUBLES AUTO-IMMUNS A L'AIDE D'ANTICORPS CIBLANT LES CELLULES B
German Title of Invention:
IMMUNTHERAPIE VON AUTOIMMUNERKRANKUNGEN DURCH DIE VERWENDUNG VON B-ZELL SPEZIFISCHEN ANTIKÖRPERN
SPC Number:

Dates

Filing date:
09/06/2000
Grant date:
19/08/2009
EP Publication Date:
19/08/2009
PCT Publication Date:
14/12/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/04/2002
EP B1 Publication Date:
19/08/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/06/2017
Expiration date:
09/06/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/06/2000
 
 

Name:
Immunomedics Inc.
Address:
300 American Road, Morris Plains, NJ 07950, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/09/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
GOLDENBERG David, M.
Address:
United States (US)

2

Name:
HANSEN Hans, J.
Address:
United States (US)

Priority

Priority Number:
138284 P
Priority Date:
09/06/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/06/2016
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages